Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 90721 - 90740 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Canada | (N02CD02) galcanezumab (adm: P) | Emgality (prefilled syringe) | Liq/Liq. SC 120 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | LIL |
| Canada | (N02CD03) fremanezumab (adm: P) | Ajovy (autoinjector) | Liq/Liq. SC 225 mg / 1.5 mL,Autoinjector / auto-injecteur | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | TEV |
| Canada | (N02CD03) fremanezumab (adm: P) | Ajovy (prefilled syringe) | Liq/Liq. SC 225 mg / 1.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | TEV |
| Canada | (N02CD05) eptinezumab (adm: P) | Vyepti | Liq/Liq. IV 300 mg / 3 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | VLH |
| Canada | (N02CD05) eptinezumab (adm: P) | Vyepti | Liq/Liq. IV 100 mg/mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Migraine Disorders | VLH |
| Canada | (N03AB02) phenytoin (adm: O) | Dilantin 30 | Sus/Susp. Orl 30 mg / 5 mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BGP |
| Canada | (N03AB02) phenytoin (adm: O) | Dilantin | Cap/Caps. Orl 30 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BGP |
| Canada | (N03AF02) oxcarbazepine (adm: O) | Trileptal | Sus/Susp. Orl 60 mg/mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NVR |
| Canada | (N03AX09) lamotrigine (adm: O) | Lamictal Chewtabs | TabC/Co.Croq. Orl 2 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GSK |
| Canada | (N03AX09) lamotrigine (adm: O) | Lamictal Chewtabs | TabC/Co.Croq. Orl 5 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GSK |
| Canada | (N03AX11) topiramate (adm: O) | Topamax | Cap/Caps. Orl 15 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
| Canada | (N03AX11) topiramate (adm: O) | Topamax | Cap/Caps. Orl 25 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
| Canada | (N03AX14) levetiracetam (adm: O) | pdp-Levetiracetam | Liq/Liq. Orl 100 mg/mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PDP |
| Canada | (N03AX17) stiripentol (adm: O) | Diacomit | Cap/Caps. Orl 250 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Myoclonic Epilepsy, Juvenile | BOX |
| Canada | (N03AX17) stiripentol (adm: O) | Diacomit | Cap/Caps. Orl 500 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Myoclonic Epilepsy, Juvenile | BOX |
| Canada | (N03AX17) stiripentol (adm: O) | Diacomit | Pws/Pd.S Orl 250 mg,Sachet / sachet | Ex-factory price without vat |
$0-0 |
$0-0 |
Myoclonic Epilepsy, Juvenile | BOX |
| Canada | (N04BA02) levodopa and decarboxylase inhibitor (adm: O, refers to levodopa) | Prolopa | Cap/Caps. Orl 50 mg / 12.5 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HLR |
| Canada | (N04BA02) levodopa and decarboxylase inhibitor (adm: O, refers to levodopa) | Prolopa | Cap/Caps. Orl 100 mg / 25 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HLR |
| Canada | (N04BA02) levodopa and decarboxylase inhibitor (adm: O, refers to levodopa) | Prolopa | Cap/Caps. Orl 200 mg / 50 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HLR |
| Canada | (N04BC09) rotigotine (adm: TD, patch) | Neupro | Pth/T.C. Trd 2 mg,Patch / timbre cutané | Ex-factory price without vat |
$0-0 |
$0-0 |
Restless Legs Syndrome;Parkinson Disease | UCB |
